Professional
Added to YB: 2025-03-27
Pitch date: 2025-03-22
LFMD [bullish]
LifeMD, Inc.
-57.37%
current return
Author Info
No bio for this author
Company Info
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States.
Market Cap
$147.0M
Pitch Price
$5.77
Price Target
14.00 (+469%)
Dividend
N/A
EV/EBITDA
-7.32
P/E
-5.51
EV/Sales
0.67
Sector
Health Care Technology
Category
growth
LifeMD (LFMD): H.C. Wainwright Reiterates Buy with $14 PT
LFMD: HC Wainwright reiterates Buy, $14 PT. Q4 revenue beat, telehealth rev up YoY. Active subs growing. 2025 product launches, LillyDirect integration, behavioral/women's health expansion. Positive cash flow, adj EBITDA. Strong financials & growth potential in telemedicine.
Read full article (1 min)